Rosiglitazone role in the expression of KLF6 caco-2 colon cancer cells
Int. j. morphol; 35 (1), 2017
Kruppel-like factor 6 (KLF6) is a member of the family of Kruppel transcription factors, this plays an important role in the regulation of cell growth, differentiation and angiogenesis. Rosiglitazone is a PPARy agonist drug, its antitumor effect has been described in models of breast and colon cancer. Th...